Andreas Mühlemann

592 total citations
10 papers, 472 citations indexed

About

Andreas Mühlemann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Andreas Mühlemann has authored 10 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 2 papers in Epidemiology. Recurrent topics in Andreas Mühlemann's work include Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and Ion channel regulation and function (3 papers). Andreas Mühlemann is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (4 papers) and Ion channel regulation and function (3 papers). Andreas Mühlemann collaborates with scholars based in Switzerland, Germany and United Kingdom. Andreas Mühlemann's co-authors include Richard H. Porter, Pari Malherbe, Georg Jaeschke, Jürgen Wichmann, Eric Prinssen, Sabine Kolczewski, Bernd Büttelmann, Theresa M. Ballard, S. Gatti and Will Spooren and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Human Molecular Genetics.

In The Last Decade

Andreas Mühlemann

9 papers receiving 460 citations

Peers

Andreas Mühlemann
Katrien Coen Belgium
Anitha P. Govind United States
Emer Leahy United States
Sangeetha Iyer United States
Elisha D.W. Mackey United States
Casey L. Kilpatrick United States
Chantelle Fourie New Zealand
Elaine A. Gay United States
Andreas Mühlemann
Citations per year, relative to Andreas Mühlemann Andreas Mühlemann (= 1×) peers Theresa M. Cabrera-Vera

Countries citing papers authored by Andreas Mühlemann

Since Specialization
Citations

This map shows the geographic impact of Andreas Mühlemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Mühlemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Mühlemann more than expected).

Fields of papers citing papers by Andreas Mühlemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Mühlemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Mühlemann. The network helps show where Andreas Mühlemann may publish in the future.

Co-authorship network of co-authors of Andreas Mühlemann

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Mühlemann. A scholar is included among the top collaborators of Andreas Mühlemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Mühlemann. Andreas Mühlemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Siegrist, Romain, et al.. (2025). Discovery and In-Vivo Characterization of Kv7 Channel Openers through a Phenotypic Approach. Journal of Medicinal Chemistry. 68(16). 17412–17426.
2.
Siegrist, Romain, Jens‐Uwe Peters, Christopher Kohl, et al.. (2025). Discovery of a New Class of Orexin 2 Receptor Agonists as a Potential Treatment for Narcolepsy. Journal of Medicinal Chemistry. 68(10). 10173–10189. 1 indexed citations
3.
Welford, Richard W.D., Andreas Mühlemann, Peter Groenen, et al.. (2018). Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. Human Molecular Genetics. 27(19). 3392–3403. 31 indexed citations
4.
Welford, Richard W.D., Andreas Mühlemann, David A. Priestman, et al.. (2017). Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence. Molecular Genetics and Metabolism. 120(1-2). S139–S140. 7 indexed citations
5.
Malherbe, Pari, Nicole A. Kratochwil, Andreas Mühlemann, et al.. (2006). Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP. Journal of Neurochemistry. 98(2). 601–615. 59 indexed citations
6.
Mühlemann, Andreas, Nicole A. Kratochwil, Catherine Diener, et al.. (2005). Determination of key amino acids implicated in the actions of allosteric modulation by 3,3′-difluorobenzaldazine on rat mGlu5 receptors. European Journal of Pharmacology. 529(1-3). 95–104. 49 indexed citations
7.
Porter, Richard H., Georg Jaeschke, Will Spooren, et al.. (2005). Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity. Journal of Pharmacology and Experimental Therapeutics. 315(2). 711–721. 246 indexed citations
8.
Mühlemann, Andreas, et al.. (2005). Constitutive activity modulation of human metabotropic glutamate 5a receptors in HEK293 cells: a role for key amino‐terminal cysteine residues. British Journal of Pharmacology. 144(8). 1118–1125. 5 indexed citations
9.
Kratochwil, Nicole A., Pari Malherbe, Lothar Lindemann, et al.. (2005). An Automated System for the Analysis of G Protein-Coupled Receptor Transmembrane Binding Pockets:  Alignment, Receptor-Based Pharmacophores, and Their Application. Journal of Chemical Information and Modeling. 45(5). 1324–1336. 50 indexed citations
10.
Mottet, Geneviève, et al.. (1996). A Sendai Virus Vector Leading to the Efficient Expression of Mutant M Proteins Interfering with Virus Particle Budding. Virology. 221(1). 159–171. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026